Resolution of, and risk of incident non-alcoholic fatty liver disease with changes in serum 25-hydroxy vitamin D status
The Journal of Clinical Endocrinology & Metabolism, 2022•academic.oup.com
Context A protective or causative role of vitamin D status on the risk of nonalcoholic fatty liver
disease (NAFLD) remains inconclusive. Objective To evaluate the association between
changes in serum 25-hydroxyvitamin D [25 (OH) D] status during follow-up and the risk of
incident NAFLD and resolution of preexisting NAFLD. Design A retrospective cohort study.
Setting Kangbuk Samsung Health Study based on routine health screening examinations.
Participants Korean adults (mean age, 36.8 years; range, 18-96 years) who underwent …
disease (NAFLD) remains inconclusive. Objective To evaluate the association between
changes in serum 25-hydroxyvitamin D [25 (OH) D] status during follow-up and the risk of
incident NAFLD and resolution of preexisting NAFLD. Design A retrospective cohort study.
Setting Kangbuk Samsung Health Study based on routine health screening examinations.
Participants Korean adults (mean age, 36.8 years; range, 18-96 years) who underwent …
Context
A protective or causative role of vitamin D status on the risk of nonalcoholic fatty liver disease (NAFLD) remains inconclusive.
Objective
To evaluate the association between changes in serum 25-hydroxyvitamin D [25(OH)D] status during follow-up and the risk of incident NAFLD and resolution of preexisting NAFLD.
Design
A retrospective cohort study.
Setting
Kangbuk Samsung Health Study based on routine health screening examinations.
Participants
Korean adults (mean age, 36.8 years; range, 18-96 years) who underwent comprehensive health examinations including assessment of serum 25(OH)D levels
Main Outcome Measures
The main outcomes were (1) incidence and (2) resolution of NAFLD assessed by liver ultrasound. Cox proportional hazard models were used to estimate hazard ratios (HRs) with 95% CIs for outcomes according to serum 25(OH)D levels.
Results
Among 139 599 participants without NAFLD at baseline, 27 531 developed NAFLD during follow-up. Serum 25(OH)D levels were significantly and inversely associated with NAFLD development. Among 48 702 participants with NAFLD at baseline, 13 449 showed NAFLD resolution. Multivariable-adjusted HR (95% CI) for NAFLD resolution comparing 25(OH)D 10 to <20, 20 to <30, and ≥30 ng/mL to <10 ng/mL were 1.09 (1.03-1.15), 1.13 (1.06-1.21), and 1.21 (1.09-1.35), respectively. Additionally, an increase in 25(OH)D levels between baseline and the subsequent visit (median, 1.8 years) was associated with decreased NAFLD incidence, while persistently adequate 25(OH)D levels over time was associated with decreased incidence and increased resolution of NAFLD.
Conclusions
Maintaining adequate serum 25(OH)D concentrations may be beneficial for both prevention as well as resolution of NAFLD.
Oxford University Press